We have been married for 3 years with at least three spontaneous abortions, our karyotype analysis showed no abnormality, so the doctor advised us to try preimplantation genetic testing for aneuploidy (PGT-A) and we finally get 3 embryos. ''I won’t delve too much into our pre-PGT-A story, despite never having seen a case in either of our families. We decided that we weren’t willing to gamble on the one-in-four chance of conceiving naturally and having a baby with the disease. We went through the standard IVF process. I spent a lot of that time getting into the best shape I’ve ever been in my life, to improve our chances. PGT-A result showed that there are two blastocysts without abnormal chromosomes. After a comprehensive evaluation, the doctor finally selected Embryo1 for implantation. I have successfully got pregnant and all test indexes are absolutely perfect.
How does the basecare PGT-A process works?
Basecare will work closely with your reproductive endocrinologist and IVF laboratory to test each of your embryos for aneuploidy.
Preimplantation genetic testing (PGT) can help identify the embryos that are most suitable for transfer during IVF to give you the best chance of implantation and a successful pregnancy. This test works by identifying embryos with extra or missing chromosomes or pieces of chromosomes.
Who benefits form PGT-A?
Women of advanced maternal age (typically 38 or older)
Women or couples with unexplained infertility
People who have experienced previous IVF failure
Women who have had recurrent miscarriages(≥2 times)
Women who have had a previous abnormal pregnancy or a child with genetic conditions
The first PGT-A kit approved by CFDA (Approval No. 20203400181)
Increase pregnancy rate to 72%, decrease miscarriage rate to 6.9%
Screen aneuploidy of full 23 pairs chromosomes at a time
High resolution for new recurring chromosome abnormality (≥4M)
Up to 200,000 yuan health insurance to protect patients interests
Well-established quality control system, rich experience in embryo detection